Logo image of TOM2.AS

TOMTOM NV (TOM2.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:TOM2 - NL0013332471 - Common Stock

6.8 EUR
0 (0%)
Last: 1/16/2026, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TOM2. TOM2 was compared to 125 industry peers in the Software industry. While TOM2 seems to be doing ok healthwise, there are quite some concerns on its profitability. TOM2 has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • TOM2 had negative earnings in the past year.
  • TOM2 had a positive operating cash flow in the past year.
  • In the past 5 years TOM2 always reported negative net income.
  • In multiple years TOM2 reported negative operating cash flow during the last 5 years.
TOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFTOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.47%, TOM2 is doing worse than 61.60% of the companies in the same industry.
  • TOM2 has a worse Return On Equity (-13.13%) than 71.20% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.14%, TOM2 is in line with its industry, outperforming 54.40% of the companies in the same industry.
Industry RankSector Rank
ROA -2.47%
ROE -13.13%
ROIC 2.14%
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
TOM2.AS Yearly ROA, ROE, ROICTOM2.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

  • TOM2 has a Operating Margin of 2.34%. This is comparable to the rest of the industry: TOM2 outperforms 50.40% of its industry peers.
  • The Gross Margin of TOM2 (88.02%) is better than 84.80% of its industry peers.
  • TOM2's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.34%
PM (TTM) N/A
GM 88.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
TOM2.AS Yearly Profit, Operating, Gross MarginsTOM2.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TOM2 is destroying value.
  • The number of shares outstanding for TOM2 has been reduced compared to 1 year ago.
  • TOM2 has less shares outstanding than it did 5 years ago.
  • TOM2 has a worse debt/assets ratio than last year.
TOM2.AS Yearly Shares OutstandingTOM2.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOM2.AS Yearly Total Debt VS Total AssetsTOM2.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • The Debt to FCF ratio of TOM2 is 4.48, which is a neutral value as it means it would take TOM2, 4.48 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of TOM2 (4.48) is comparable to the rest of the industry.
  • TOM2 has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
  • TOM2 has a Debt to Equity ratio (0.23) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 4.48
Altman-Z N/A
ROIC/WACC0.27
WACC8.06%
TOM2.AS Yearly LT Debt VS Equity VS FCFTOM2.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.71 indicates that TOM2 should not have too much problems paying its short term obligations.
  • TOM2 has a better Current ratio (1.71) than 61.60% of its industry peers.
  • TOM2 has a Quick Ratio of 1.67. This is a normal value and indicates that TOM2 is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.67, TOM2 is in the better half of the industry, outperforming 63.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.67
TOM2.AS Yearly Current Assets VS Current LiabilitesTOM2.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

  • TOM2 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.08%, which is quite impressive.
  • Looking at the last year, TOM2 shows a decrease in Revenue. The Revenue has decreased by -1.70% in the last year.
  • The Revenue has been decreasing by -3.90% on average over the past years.
EPS 1Y (TTM)28.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%275%
Revenue 1Y (TTM)-1.7%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%-2.7%

3.2 Future

  • Based on estimates for the next years, TOM2 will show a very strong growth in Earnings Per Share. The EPS will grow by 66.61% on average per year.
  • Based on estimates for the next years, TOM2 will show a small growth in Revenue. The Revenue will grow by 7.40% on average per year.
EPS Next Y30.35%
EPS Next 2Y103.54%
EPS Next 3Y66.61%
EPS Next 5YN/A
Revenue Next Year-2.86%
Revenue Next 2Y-0.8%
Revenue Next 3Y0.42%
Revenue Next 5Y7.4%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TOM2.AS Yearly Revenue VS EstimatesTOM2.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
TOM2.AS Yearly EPS VS EstimatesTOM2.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

3

4. Valuation

4.1 Price/Earnings Ratio

  • TOM2 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 33.33, TOM2 can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as TOM2.
  • The average S&P500 Price/Forward Earnings ratio is at 24.26. TOM2 is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 33.33
TOM2.AS Price Earnings VS Forward Price EarningsTOM2.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

  • 78.40% of the companies in the same industry are more expensive than TOM2, based on the Enterprise Value to EBITDA ratio.
  • TOM2's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 98.6
EV/EBITDA 11.49
TOM2.AS Per share dataTOM2.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • TOM2's earnings are expected to grow with 66.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y103.54%
EPS Next 3Y66.61%

0

5. Dividend

5.1 Amount

  • TOM2 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

TOMTOM NV

AMS:TOM2 (1/16/2026, 7:00:00 PM)

6.8

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-14
Earnings (Next)02-02
Inst Owners18.59%
Inst Owner ChangeN/A
Ins Owners51.4%
Ins Owner ChangeN/A
Market Cap850.00M
Revenue(TTM)565.73M
Net Income(TTM)-17.25M
Analysts76
Price Target6.09 (-10.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-8.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 33.33
P/S 1.5
P/FCF 98.6
P/OCF 23.89
P/B 6.47
P/tB N/A
EV/EBITDA 11.49
EPS(TTM)-0.15
EYN/A
EPS(NY)0.2
Fwd EY3%
FCF(TTM)0.07
FCFY1.01%
OCF(TTM)0.28
OCFY4.19%
SpS4.53
BVpS1.05
TBVpS-0.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.47%
ROE -13.13%
ROCE 2.86%
ROIC 2.14%
ROICexc 5.05%
ROICexgc N/A
OM 2.34%
PM (TTM) N/A
GM 88.02%
FCFM 1.52%
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 4.48
Debt/EBITDA 0.86
Cap/Depr 119.93%
Cap/Sales 4.77%
Interest Coverage 7.61
Cash Conversion 99.6%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.67
Altman-Z N/A
F-Score6
WACC8.06%
ROIC/WACC0.27
Cap/Depr(3y)20.27%
Cap/Depr(5y)16.21%
Cap/Sales(3y)1.63%
Cap/Sales(5y)1.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%275%
EPS Next Y30.35%
EPS Next 2Y103.54%
EPS Next 3Y66.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.7%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%-2.7%
Revenue Next Year-2.86%
Revenue Next 2Y-0.8%
Revenue Next 3Y0.42%
Revenue Next 5Y7.4%
EBIT growth 1Y153.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year231.43%
EBIT Next 3Y82.1%
EBIT Next 5YN/A
FCF growth 1Y260.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y643.79%
OCF growth 3Y-66.75%
OCF growth 5Y-57.16%

TOMTOM NV / TOM2.AS FAQ

What is the ChartMill fundamental rating of TOMTOM NV (TOM2.AS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to TOM2.AS.


What is the valuation status for TOM2 stock?

ChartMill assigns a valuation rating of 3 / 10 to TOMTOM NV (TOM2.AS). This can be considered as Overvalued.


Can you provide the profitability details for TOMTOM NV?

TOMTOM NV (TOM2.AS) has a profitability rating of 2 / 10.


How financially healthy is TOMTOM NV?

The financial health rating of TOMTOM NV (TOM2.AS) is 4 / 10.